Olivier Lambotte
Inserm(FR)Inserm(FR)Commissariat à l'Énergie Atomique et aux Énergies Alternatives(FR)Commissariat à l'Énergie Atomique et aux Énergies Alternatives(FR)Université Paris-Saclay(FR)CEA Paris-Saclay - Etablissement de Fontenay-aux-roses(FR)Assistance Publique – Hôpitaux de Paris(FR)CEA Paris-Saclay(FR)Infectious Disease Models and Innovative Therapies(FR)National Center for Infectious Diseases(US)Bicêtre Hospital(FR)Bicêtre Hospital(FR)
Publications by Year
Research Areas
HIV Research and Treatment, Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers, HIV/AIDS Research and Interventions, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Microbial translocation is a cause of systemic immune activation in chronic HIV infection(2006)3,514 cited
- → Immune-related adverse events with immune checkpoint blockade: a comprehensive review(2016)2,094 cited
- → Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome(2014)1,367 cited
- → Immune-related adverse events of checkpoint inhibitors(2020)1,326 cited
- → Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination(2016)1,087 cited
- → Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study(2013)990 cited